Achieving Success by Leveraging Federal Labs as Technology Development and Commercialization Partners
Are you interested in partnering with a federal lab on vaccine technology? If so, you do not want to miss the National Cancer Institute’s Michael Salgaller speaking at the World Vaccine Congress Washington. This event will feature industry experts across the entire vaccine landscape and feature sessions on COVID-19. This conference will be a convergence of science, government, and manufacturers discussing the entire vaccine value chain.
Michael Salgaller leads the Invention Development and Marketing Unit (IDMU) within the Technology Transfer Center at NCI. He has over 20 years of scientific and investment experience and is ready to help foster licensing and collaboration activities between your organization and NCI. Salgaller’s panel will be focused on Achieving Success by Leveraging Federal Labs as Technology Development and Commercialization Partners. The panel will take place on the last day of the conference, April 21st, at 9:55 A.M.
The World Vaccine Congress Washington will take place from April 18-21st at the Marriott Marquis Washington DC. You can find more information on their website.
If you are interested in licensing or collaborating on an NIH vaccine technology, you can browse available technologies here.